FMR LLC 13D and 13G filings for Relay Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-07-10 10:20 am Sale | 2023-07-07 | 13G | Relay Therapeutics, Inc. RLAY | FMR LLC | 2,956,221 2.430% | -6,777,627 (-69.63%) | Filing |
| 2023-02-09 12:31 pm Sale | 2023-02-09 | 13G | Relay Therapeutics, Inc. RLAY | FMR LLC | 9,733,848 8.051% | -2,224,364 (-18.60%) | Filing |
| 2022-10-11 09:03 am Sale | 2022-10-07 | 13G | Relay Therapeutics, Inc. RLAY | FMR LLC | 11,958,212 9.947% | -4,248,389 (-26.21%) | Filing |
| 2022-02-09 10:24 am Purchase | 2022-02-08 | 13G | Relay Therapeutics, Inc. RLAY | FMR LLC | 16,206,601 14.999% | 5,844,601 (+56.40%) | Filing |
| 2021-07-12 12:07 pm Purchase | 2021-07-09 | 13G | Relay Therapeutics, Inc. RLAY | FMR LLC | 10,362,000 11.216% | 5,599,762 (+117.59%) | Filing |
| 2021-02-08 10:31 am Purchase | 2021-02-05 | 13G | Relay Therapeutics, Inc. RLAY | FMR LLC | 4,762,238 5.292% | 4,762,238 (New Position) | Filing |